King-Friend Biochemical Pharmaceutical Co. Ltd.
King-Friend Biochemical Pharmaceutical Co. Ltd., commonly referred to as King-Friend, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and production of high-quality biochemical products, primarily focusing on APIs (Active Pharmaceutical Ingredients) and intermediates. With a strong operational presence across various regions, King-Friend has built a reputation for its innovative solutions in the pharmaceutical sector. The company’s core offerings include a diverse range of pharmaceutical raw materials, which are distinguished by their purity and compliance with international standards. Recognised for its commitment to quality and sustainability, King-Friend has achieved notable milestones, positioning itself as a trusted partner in the global pharmaceutical supply chain. Its dedication to research and development continues to drive its success in an increasingly competitive market.
DitchCarbon Score
How does King-Friend Biochemical Pharmaceutical Co. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
King-Friend Biochemical Pharmaceutical Co. Ltd.'s score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
King-Friend Biochemical Pharmaceutical Co. Ltd.'s reported carbon emissions
As of the latest available data, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. has not disclosed specific carbon emissions figures for recent years. However, the company is committed to reducing its carbon footprint, as indicated by its near-term target status, which is classified as "Committed." Operating in the Pharmaceuticals, Biotechnology, and Life Sciences sector in China, King-Friend Biochemical is actively engaging in climate initiatives, although it has not set a net-zero target or specified long-term reduction goals. The absence of detailed emissions data highlights a common challenge within the industry, where many companies are still in the early stages of formalising their climate commitments. The company’s commitment to reducing emissions aligns with broader industry trends, as pharmaceutical companies increasingly recognise the importance of sustainability and climate action. While specific reduction targets have not been outlined, King-Friend Biochemical's commitment status suggests a proactive approach to addressing climate change and improving environmental performance.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
King-Friend Biochemical Pharmaceutical Co. Ltd. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
